For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Pfizer Corporation

USPTO Granted Patents = 4,488

% Expired Patents = 23.0

CIPO Patents = 202

EPO Patents = 378

Trademarks = 301

Forward Citations = 41,479

Loading Chart...

Loading Chart...

3,663 inventors (with patents filed for the assignee):

Peter E Cross (95 out of 96 patents)

Michael Ross Johnson (84 out of 170 patents)

Junsuke Tone (60 out of 60 patents)

4. Walter P Cullen (60 out of 60 patents)

5. Patrick Robert Verhoest (58 out of 59 patents)

6. Lawrence S Melvin, Jr (57 out of 57 patents)

7. Michael Aaron Brodney (55 out of 65 patents)

8. David Andrew Griffith (55 out of 65 patents)

9. Kenneth Richardson (52 out of 52 patents)

10. Anthony Marfat (50 out of 62 patents)

11. Robert L Dow (50 out of 66 patents)

12. Brian Thomas O'Neill (48 out of 54 patents)

13. John Adams Lowe, Iii (48 out of 83 patents)

14. Bruce A Lefker (48 out of 50 patents)

15. Reinhard Sarges (47 out of 47 patents)

Core Competencies:

Immunogenic Compositions

GLP-1 Receptor Agonists

Anti-Cancer Antibodies

NASH/NAFLD Treatments

Pharmaceutical Compounds

Chimeric Antigen Receptors

CDK Inhibitors

Tumor Necrosis Factor

Antibody Drug Conjugates

Benzodioxol Derivatives

Protease Activators

Diagnostic Devices

4,488 patents: Sort by Forward Citations

1. 12760019 - SIK inhibitors (2026-10-13),

2. 12758718 - System and method for needle hiding in injectors (2026-10-13),

3. 12734231 - Cell culture process for producing RSV F protein (2026-09-15),

4. 12715863 - 5-(thiophen-2-yl)-1 H-tetrazole derivative as BCKDK inhibitors useful for treating various diseases (2026-08-25),

5. 12708668 - STABLE AQUEOUS ANTI-TFPI ANTIBODY FORMULATION (2026-08-18),

6. 12703696 - Diacylglycerol acyl transferase 2 inhibitors (2026-08-11),

7. 12698271 - Crystalline form of a SHP2 inhibitor (2026-08-04),

8. 12678446 - Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection (2026-07-14),

9. 12667671 - System and method for information management in computerized injectors (2026-06-30),

10. 12655161 - Solid forms of an eIF4E inhibitor (2026-06-16),

11. 12655157 - Spiro[benzo[d]thiazole-6 ,4'-piperidine as ACC inhibitors (2026-06-16),

12. 12655105 - Biphenyl and Phenylpyridine Compounds (2026-06-16),

13. 12653901 - ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES (2026-06-16),

14. 12649933 - Cells Having Gene Duplications and Uses Thereof (2026-06-09),

15. 12642803 - Pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyljurea (2026-06-02),

Company Overview

Pfizer Corporation, headquartered in New York, NY, is a leading global biopharmaceutical company dedicated to the development and manufacturing of innovative medicines and vaccines. The company specializes in a diverse range of therapeutic areas, including immunogenic compositions, GLP-1 receptor agonists, and anti-cancer antibodies. Pfizer is also actively engaged in research on treatments for NASH/NAFLD, chimeric antigen receptors, CDK inhibitors, and tumor necrosis factor, positioning itself at the forefront of pharmaceutical advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4,488 Patents

#3 in New York, NY

#7 in New York

#99 in US

#211 in the World

New York, NY, United States of America

Pfizer Corporation

Forward Citations = 41,479

3,663 inventors:

Peter E Cross (95 out of 96 patents)

Michael Ross Johnson (84 out of 170 patents)

Junsuke Tone (60 out of 60 patents)

4. Walter P Cullen (60 out of 60 patents)

5. Patrick Robert Verhoest (58 out of 59 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pfizer Corporation. Retrieved from https://idiyas.com/company/pfizer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…